Morphokinetic Markers of Blastocyst Formation and Chromosomal Euploidy in Embryos Derived From In Vitro Maturation Oocytes

Read full text
Authors: Hong Chen, Ruolin Mao, Rui Long, Juepu Zhou, Huijun Li, Qingsong Xi, Lixia Zhu, Lei Jin
Cited by: 1
References: 25

Abstract

ABSTRACT Purpose To characterize the morphokinetic parameters of embryos derived from IVM oocytes and to identify critical factors associated with blastocyst formation potential and chromosomal euploidy. Methods This retrospective study reviewed 99 523 fresh cycles between January 2019 and March 2025. From this population, 3,202 PGT cycles were initially screened. A total of 353 cycles involving IVM oocytes were then selected, and ultimately, 83 IVM‐derived embryos from 59 cycles were included. Results The non‐formation group exhibited delays in t2, t9, and several developmental intervals, including S2, t9–t7, t9–t8 ( p < 0.05). Multivariate logistic regression analysis identified S2 ( p = 0.021) and t9–t7 ( p = 0.042) as independent factors associated with blastocyst formation. Subsequently, ROC analysis showed that both S2 ≤ 1.95 h (AUC = 0.620, p = 0.036) and t9–t7 ≤ 24.35 h (AUC = 0.672, p < 0.001) exhibited predictive power for blastocyst formation. Furthermore, shorter tSB–t9 and tB–t9 were associated with euploidy in IVM‐derived blastocysts ( p = 0.025 and p = 0.014, respectively), with tSB–t9 emerging as an independent factor associated with chromosomal normality ( p = 0.044) in multivariate analysis. Conclusions This study presents the morphokinetic characteristics and identifies key markers for blastocyst formation and chromosomal euploidy in IVM‐derived embryos.

Fields of Study & Subjects

Reproductive Biology and Fertility Prenatal Screening and Diagnostics Ovarian function and disorders

Publication details

Journal / source
Reproductive Medicine and Biology
Publisher
Wiley
Volume
25
Issue
1
Pages
e70037–e70037
Publication date
1 January 2026
Language
EN